Companies Nervous About 'Sharing' Organizations Touted In FDA Cyber Guidance
This article was originally published in The Gray Sheet
Industry groups have questions and concerns about the Information Sharing and Analysis Organizations highlighted in FDA's recent postmarket cybersecurity draft guidance. The agency's use of the term "essential clinical performance" in the document has also raised concerns, comments submitted to FDA show.
Register for our free email digests: